Jeremy R. Graff - Sep 30, 2025 Form 4 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Role
President and Chief Development Officer
Signature
/s/ Jeremy R. Graff
Stock symbol
ALLR
Transactions as of
Sep 30, 2025
Transactions value $
-$23,089
Form type
4
Date filed
10/2/2025, 04:05 PM
Previous filing
May 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Graff Jeremy R. President and Chief Development Officer C/O ALLARITY THERAPEUTICS, INC, 123 E TARPON AVE, TARPON SPRINGS /s/ Jeremy R. Graff 2025-10-02 0001975028

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLR Common Stock Options Exercise +39.5K 39.5K Sep 30, 2025 Direct F1
transaction ALLR Common Stock Tax liability -$23.1K -14.6K -37% $1.58 24.9K Sep 30, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLR Restricted Stock Units Options Exercise $0 -39.5K -15.02% $0.00 223K Sep 30, 2025 Common Stock 39.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

Remarks:

President and Chief Development Officer